Streetbeat News

Earnings

GRTX

QLI

SBFM

VVOS

In Friday's after-market session, several healthcare stocks showed significant movement. Notably, Qilian Intl Hldg Gr, Sunshine Biopharma, and Galera Therapeutics were among the top gainers, with Qilian Intl leading with a 63.8% increase. On the downside, Vivos Therapeutics, ENDRA Life Sciences, and Applied Therapeutics experienced notable declines, with Vivos Therapeutics dropping 22.4%. The movements were largely attributed to the release of Q4 earnings reports for some companies.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 8:30 pm

ATAI

META

MNMD

PSIL

TSLA

Beckley Psytech and atai Life Sciences announced positive results from a Phase 2a study of 5-MeO-DMT for Treatment Resistant Depression. Utah hospitals will soon offer psilocybin and MDMA therapy. Elon Musk discussed the benefits of ketamine for depression and its positive impact on investors. Meta is under investigation for potentially facilitating illegal drug sales. MindMed's CEO highlighted LSD's potential in a podcast. Various companies and ETFs are mentioned with their stock performance.

Portfolio Pulse from Lara Goldstein

March 29, 2024 | 4:43 pm

PIK

VEEE

In Friday's intraday session, several consumer discretionary stocks experienced significant movements. Kidpik, Mullen Automotive, Fitell, RH, GEN Restaurant Gr, and Dogness saw their shares rise, with RH's increase attributed to its Q4 earnings report. Conversely, Selina Hospitality, SRIVARU Holding, Twin Vee PowerCats, NWTN, Dixie Gr, and MGO Global faced declines, with Twin Vee PowerCats' drop following its Q4 earnings.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 4:31 pm

AVTX

KOD

NDRA

TNXP

In Friday's intraday session, several healthcare stocks experienced significant movements. Avalo Therapeutics led the gainers with a 364.8% increase, while Tonix Pharmaceuticals headed the losers with a 45.4% decrease. Other notable movers include Nexalin Technology and Biodexa Pharmaceuticals with substantial gains, and Kodiak Sciences and ENDRA Life Sciences among the losers, with their recent Q4 earnings reports influencing their stock prices.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 4:30 pm

NEOV

PMEC

UGRO

VSTE

In Friday's intraday session, several industrials stocks experienced significant movements. Vast Renewables, NeoVolta, SolarMax Technology, Nikola, Nuvve Holding, and Li-Cycle Holdings were among the gainers, with increases ranging from 13.35% to 33.1%. On the downside, Primech Holdings, Urban-gro, MillerKnoll, Ryde Group, Shimmick, and ShiftPixy saw declines between 9.28% and 67.3%. Notably, earnings reports influenced some of these movements.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 4:30 pm

AMZN

The article compares Amazon.com (AMZN) with its competitors in the Broadline Retail industry, analyzing financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Amazon's valuation is higher than the industry average, indicating a potentially overvalued stock. Despite strong operational performance as shown by high EBITDA and gross profit, Amazon's revenue growth is lower than the industry average, suggesting slower expansion.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 3:00 pm

NVDA

A comprehensive analysis of NVIDIA (NVDA) and its competitors in the Semiconductors & Semiconductor Equipment industry reveals NVIDIA's strong market positioning. With a P/E ratio slightly below the industry average, and significantly higher P/B and P/S ratios, NVIDIA might be seen as trading at a premium. However, its exceptional ROE, EBITDA, gross profit, and revenue growth, all substantially above industry averages, underscore its operational efficiency and profitability. NVIDIA's lower debt-to-equity ratio compared to its top 4 peers further highlights its solid financial health.

Portfolio Pulse from Benzinga Insights

March 29, 2024 | 3:00 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is anticipated to report a decline in Q1 deliveries compared to Q4, with analysts cutting their delivery estimates due to concerns over electric vehicle demand, China, and macroeconomic factors. Wedbush analyst Daniel Ives reduced his price target for Tesla from $315 to $300 and lowered his delivery estimates, describing Q1 as a 'nightmare quarter' for Tesla. Other analysts have also revised their estimates downward, and Tesla's year-to-date shares have fallen by 29%. A weak Q1 delivery report could further depress Tesla's stock price.

Portfolio Pulse from Chris Katje

March 29, 2024 | 2:44 pm

SPY

The PCE inflation rate rose to 2.5% in February, with personal spending exceeding expectations. Despite a slight monthly dip in inflation, the core annual rate was revised higher, indicating persistent inflation. Analysts offer mixed views on future Fed actions, with some predicting rate cuts by June due to slowing consumer spending and service inflation, while others highlight above-target inflation rates suggesting continued or increased rates.

Portfolio Pulse from Neil Dennis

March 29, 2024 | 2:20 pm

AMC

CGC

IONQ

MSTR

Benzinga's Stock Whisper Index highlights Canopy Growth Corp, JD.Com Inc, MicroStrategy Inc, AMC Entertainment Holdings Inc, and IonQ Inc as stocks to watch. Canopy Growth benefits from Germany's cannabis legalization, JD.Com sees investor interest post-earnings, MicroStrategy's Bitcoin strategy draws attention, AMC plans a stock offering, and IonQ announces strategic agreements and a new team member.

Portfolio Pulse from Chris Katje

March 29, 2024 | 2:01 pm